The Ministry of Health, Welfare and Family Affairs announced on March 30 that seven generic drugs must be taken off the market due to lack of economic effectiveness.
Hyperlipemia drugs produced by Young Pharm, Otsuka Korea, Korea Core, Korea Wales, Korea Meditec, Sam-A and Korea Pharm proved to be sub-par, according to the ministry.
Sales for hyperlipemia drugs reached 11.7 billion won la...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.